Several approved studies are underway, including work at UBC, and another study in Albany New York, partially funded by the province of Saskatchewan.
The FDA's warning does not affect Saskatchewan MS patients traveling to participate in the clinical trial at the Albany Medical Center, a spokesperson for the government of Saskatchewan wrote to CTV . The FDA Gave final approval to the research protocol May 4, 2012.


FDA warns against unapproved 'liberation' studies | CTV News
www.ctv.ca
The U.S. Food and Drug Administration has issued a warning to U.S. clinics performing studies on angioplasty as a treatment for multiple sclerosis, saying any studies on the procedure need FDA approval.